Cyclin-Dependent Kinase Inhibitor 2B Regulates Efferocytosis and Atherosclerosis

Journal of Clinical Investigation - United States
doi 10.1172/jci129277
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Cyclin-Dependent Kinase Inhibitor, P21Waf1, Regulates Vascular Smooth Muscle Cell Hypertrophy

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2004English

Skap2 Regulates Atherosclerosis Through Macrophage Polarization and Efferocytosis

2019English

CyclinA2-Cyclin-dependent Kinase Regulates SAMHD1 Protein Phosphohydrolase Domain

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

Preliminary Crysallization of a Cyclin-Dependent Kinase Inhibitor: P18

Acta Crystallographica Section A Foundations of Crystallography
1996English

ETS Proto-Oncogene 1 Transcriptionally Up-Regulates the Cholangiocyte Senescence-Associated Protein Cyclin-Dependent Kinase Inhibitor 2A

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Modulation of Apoptosis by the Cyclin-Dependent Kinase Inhibitor P27Kip1

Journal of Clinical Investigation
Medicine
1999English

The Cyclin-Dependent Kinase Inhibitor P27Kip1 Induces N-Terminal Proteolytic Cleavage of Cyclin A

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Cyclin-Dependent Kinase 5 Regulates Dopaminergic and Glutamatergic Transmission in the Striatum

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

Regulation of Protein Phosphatase Inhibitor-1 by Cyclin-Dependent Kinase 5

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy